--- title: "U.S. Stock Market Midday Update: HIMS up 10.44%: Q2 revenue exceeds expectations, AI transformation boosts confidence" type: "News" locale: "en" url: "https://longbridge.com/en/news/296389175.md" description: "Hims & Hers Health rose 10.44%; SiVis fell 0.59%, with a transaction volume of USD 304 million; Guardant Health rose 0.89%, with a transaction volume of USD 214 million; Cigna Insurance rose 0.51%, with a transaction volume of USD 105 million; Quest Diagnostics rose 2.15%, with a market value of USD 26.7 billion" datetime: "2026-08-19T18:33:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296389175.md) - [en](https://longbridge.com/en/news/296389175.md) - [zh-HK](https://longbridge.com/zh-HK/news/296389175.md) generator: "portal-rs" --- # U.S. Stock Market Midday Update: HIMS up 10.44%: Q2 revenue exceeds expectations, AI transformation boosts confidence **U.S. Stock Market Midday Update** Hims & Hers Health rose 10.44%. Based on recent key news: 1. On August 20, Hims & Hers Health announced its second-quarter financial report, with revenue reaching $753 million, a year-on-year increase of 38%, exceeding market expectations, and raised its full-year performance guidance to $3.1 billion to $3.3 billion, reflecting a continued expansion of the business. This move drove the stock price up. 2. On August 19, the Federal Trade Commission's privacy protection allegations against Hims & Hers Health attracted attention, and the company's CEO responded by stating that it would transform into an AI-native organizational structure, further increasing investment in the field of artificial intelligence to enhance market confidence. 3. On August 18, the securities litigation law firm Kessler Topaz Meltzer & Check, LLP announced an investigation into Hims & Hers Health for potential violations of federal securities laws. Nevertheless, the market remains optimistic about the company's future development. The digital health industry faces compliance challenges, and AI investment is accelerating. **Stocks with High Trading Volume in the Industry** CVS Health fell 0.59%. Based on recent key news: 1. On August 17, CVS Health announced changes to its board of directors, appointing Teresa Heitsenrether as a board member while Larry Robbins left the board. This news may raise market concerns about the company's governance structure, leading to stock price fluctuations. 2. On August 18, CVS Health disclosed that its long-term debt burden exceeds $6.1 billion, with high financial leverage limiting capital allocation for stock buybacks or debt repayment. This news may raise investor concerns about the company's financial health, affecting the stock price. 3. On August 18, CVS Health was listed as one of the top dividend stocks, with moderate trading valuations. Although this news is attractive to long-term investors, it has not significantly boosted the stock price in the short term. The overall industry performance remains stable, with limited impact from macroeconomic data. Guardant Health rose 0.89%. Based on recent key news: 1. On August 18, Guardant Health received coverage for its Shield test from UnitedHealth Group, immediately boosting revenue expectations. This move significantly enhanced the company's market position, driving the stock price up. 2. On August 19, technical indicators showed that the stock is in a long-term upward trend. Although valuations remain challenging, market sentiment signals a buy, further supporting the stock price increase. 3. On August 19, Guardant Health's year-to-date price performance was 58.28%, with an average trading volume of 2,750,094, indicating sustained investor interest in the stock. The healthcare industry has performed strongly recently, with noticeable capital inflows Cigna Insurance rose by 0.51%. Based on recent news, 4. On August 17, MarketBeat pointed out that Cigna Insurance was not included in the list of the top five stocks recommended by leading analysts. Although Cigna Insurance currently has a moderate buy rating among analysts, the top analysts believe there are five stocks that are more worthy of purchase, which may affect investor confidence. 5. On August 19, MarketBeat reiterated that Cigna Insurance was not included in the list of the top five stocks recommended by leading analysts. The repeated news further weakened market confidence in Cigna Insurance, leading to stock price fluctuations. 6. No other significant news recently. Analyst rating is moderate buy, but market confidence is lacking. **Stocks ranked among the top in industry market capitalization** Quest Diagnostics rose by 2.15%. Based on recent news, 1. On August 19, MarketBeat reported that Quest Diagnostics was not recommended by leading analysts as a top investment choice, despite its moderate buy rating. This may lead some investors to reassess their investment decisions, driving the stock price up. 2. On August 18, Simply Wall St released an analysis indicating that the valuation of Quest Diagnostics is complex but provided detailed analysis, including fair value estimates, potential risks, dividends, and insider trading situations. This information may have enhanced investor confidence in the company, promoting the rise in stock price. The overall market performance is stable, with increased attention on the healthcare industry ### Related Stocks - [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md) - [CVS.US](https://longbridge.com/en/quote/CVS.US.md) - [GH.US](https://longbridge.com/en/quote/GH.US.md) - [CI.US](https://longbridge.com/en/quote/CI.US.md) - [DGX.US](https://longbridge.com/en/quote/DGX.US.md) ## Related News & Research - [Companies with huge datasets can save up to 80% in AI costs by using open-weight models: Hims CEO](https://longbridge.com/en/news/296307633.md) - [Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access](https://longbridge.com/en/news/296381732.md) - [3 arguments for and against AI watermarks](https://longbridge.com/en/news/296205500.md) - [Originalis AI Founding Engineer Ujjwal Jain Unveils AI System Processing Over 645,000 VC Email Threads](https://longbridge.com/en/news/296065185.md) - [Argentum AI Announces $10 Billion+ in Contracted Revenue and Targets 1GW of AI Infrastructure Capacity in 2026](https://longbridge.com/en/news/296261035.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**